These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 37449926)

  • 1. Preventive and therapeutic effects of natural products and herbal extracts on nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
    Cao Y; Fang X; Sun M; Zhang Y; Shan M; Lan X; Zhu D; Luo H
    Phytother Res; 2023 Sep; 37(9):3867-3897. PubMed ID: 37449926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Herbal medicines and nonalcoholic fatty liver disease.
    Yao H; Qiao YJ; Zhao YL; Tao XF; Xu LN; Yin LH; Qi Y; Peng JY
    World J Gastroenterol; 2016 Aug; 22(30):6890-905. PubMed ID: 27570425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chinese herbal medicines: The modulator of nonalcoholic fatty liver disease targeting oxidative stress.
    Gong P; Long H; Guo Y; Wang Z; Yao W; Wang J; Yang W; Li N; Xie J; Chen F
    J Ethnopharmacol; 2024 Jan; 318(Pt B):116927. PubMed ID: 37532073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current pharmacological therapies for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
    Takahashi Y; Sugimoto K; Inui H; Fukusato T
    World J Gastroenterol; 2015 Apr; 21(13):3777-85. PubMed ID: 25852263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Xuefu Zhuyu decoction for nonalcoholic fatty liver disease: A protocol for systematic review and meta-analysis.
    Liu J; Dong B; Yang L; Huang W; Tang S
    Medicine (Baltimore); 2021 May; 100(19):e25358. PubMed ID: 34106587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential Therapeutic Application of Estrogen in Gender Disparity of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis.
    Lee C; Kim J; Jung Y
    Cells; 2019 Oct; 8(10):. PubMed ID: 31619023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic Effects of microRNAs on Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH): A Systematic Review and Meta-Analysis.
    Zhu Y; Tan JK; Wong SK; Goon JA
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Animal models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
    Takahashi Y; Soejima Y; Fukusato T
    World J Gastroenterol; 2012 May; 18(19):2300-8. PubMed ID: 22654421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of newer antidiabetic drugs on nonalcoholic fatty liver and steatohepatitis: Think out of the box!
    Ranjbar G; Mikhailidis DP; Sahebkar A
    Metabolism; 2019 Dec; 101():154001. PubMed ID: 31672448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological Mechanisms and Related Natural Inhibitors of CD36 in Nonalcoholic Fatty Liver.
    Feng Y; Sun W; Sun F; Yin G; Liang P; Chen S; Liu X; Jiang T; Zhang F
    Drug Des Devel Ther; 2022; 16():3829-3845. PubMed ID: 36388082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Mechanisms of Nonalcoholic Fatty Liver Disease (NAFLD)/Nonalcoholic Steatohepatitis (NASH).
    Ota T
    Adv Exp Med Biol; 2021; 1261():223-229. PubMed ID: 33783745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural Aldose Reductase Inhibitor: A Potential Therapeutic Agent for Non-alcoholic Fatty Liver Disease.
    Qiu L; Guo C
    Curr Drug Targets; 2020; 21(6):599-609. PubMed ID: 31589122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapy for Nonalcoholic Fatty Liver Disease: Current Options and Future Directions.
    Campbell P; Symonds A; Barritt AS
    Clin Ther; 2021 Mar; 43(3):500-517. PubMed ID: 33583577
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Książek E; Goluch Z; Bochniak M
    Nutrients; 2024 Sep; 16(17):. PubMed ID: 39275255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phytotherapy as Multi-Hit Therapy to Confront the Multiple Pathophysiology in Non-Alcoholic Fatty Liver Disease: A Systematic Review of Experimental Interventions.
    Ore A; Akinloye OA
    Medicina (Kaunas); 2021 Aug; 57(8):. PubMed ID: 34441028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New therapeutic strategies in nonalcoholic fatty liver disease: a focus on promising drugs for nonalcoholic steatohepatitis.
    Pydyn N; Miękus K; Jura J; Kotlinowski J
    Pharmacol Rep; 2020 Feb; 72(1):1-12. PubMed ID: 32016853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural Active Compounds from Plant Food and Chinese Herbal Medicine for Nonalcoholic Fatty Liver Disease.
    Liu Q; Zhu L; Cheng C; Hu YY; Feng Q
    Curr Pharm Des; 2017; 23(34):5136-5162. PubMed ID: 28925892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multi-targeting strategy to ameliorate high-fat-diet- and fructose-induced (western diet-induced) non-alcoholic fatty liver disease (NAFLD) with supplementation of a mixture of legume ethanol extracts.
    Koh YC; Lin YC; Lee PS; Lu TJ; Lin KY; Pan MH
    Food Funct; 2020 Sep; 11(9):7545-7560. PubMed ID: 32815965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of Nonalcoholic Fatty Liver Disease with Long-Chain n-3 Polyunsaturated Fatty Acids in Humans.
    Kelley NS
    Metab Syndr Relat Disord; 2016 Nov; 14(9):417-430. PubMed ID: 27710160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel Statement.
    Athyros VG; Alexandrides TK; Bilianou H; Cholongitas E; Doumas M; Ganotakis ES; Goudevenos J; Elisaf MS; Germanidis G; Giouleme O; Karagiannis A; Karvounis C; Katsiki N; Kotsis V; Kountouras J; Liberopoulos E; Pitsavos C; Polyzos S; Rallidis LS; Richter D; Tsapas AG; Tselepis AD; Tsioufis K; Tziomalos K; Tzotzas T; Vasiliadis TG; Vlachopoulos C; Mikhailidis DP; Mantzoros C
    Metabolism; 2017 Jun; 71():17-32. PubMed ID: 28521870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.